# Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

> **NCT06055790** · PHASE2 · RECRUITING · sponsor: **University of Arizona** · enrollment: 20 (estimated)

## Conditions studied

- Brain Metastases

## Interventions

- **DIAGNOSTIC_TEST:** 18F-Fluciclovine (Axumin) PET/CT

## Key facts

- **NCT ID:** NCT06055790
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-10
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06055790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06055790, "Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06055790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*